GVR Report cover Remote Patient Monitoring System Market Size, Share & Trends Report

Remote Patient Monitoring System Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Vital Sign Monitor, Specialized Monitor), By End Use (Hospital Based Patient, Ambulatory Patient, Home Healthcare), By Application, By Region, And Segment Forecasts

Remote Patient Monitoring System Market Summary

The global remote patient monitoring system market size was estimated at USD 22.03 billion in 2024 and is projected to reach USD 110.71 billion by 2033, growing at a CAGR of 19.8% from 2025 to 2033. The remote monitoring systems serve with improved chronic disease management including early warning signs and progress tracker thus boosting its demand in the coming years at a global level.

Key Market Trends & Insights

  • North America dominated the market and accounted for a 40.5% share in 2024.
  • The remote patient monitoring system market in the U.S. has seen significant growth over the forecast period owing to the adoption of integrated solutions.
  • By product, the special monitors segment led the market with a share of 89.95% in 2023.
  • By application, diabetes emerged as the leading application segment in 2024 and accounted for 13.1% of the market share.
  • By end use, the hospital-based patient segment was the leading in 2024 and accounted for 61.46% of the market share.

Market Size & Forecast

  • 2024 Market Size: USD 22.03 Billion
  • 2033 Projected Market Size: USD 110.71 Billion
  • CAGR (2025-2033): 19.8%
  • North America: Largest market in 2024
  • Asia Pacific: Fastest growing market


The remote monitoring systems serve with improved chronic disease management including early warning signs and progress tracker thus boosting its demand in the coming years at a global level. The COVID-19 pandemic led to a shortage of space in hospitals. Apart from this, patients, especially those suffering from chronic diseases, were advised to avoid physical visits to hospitals owing to the threat of getting infected. This led to the development of remote patient monitoring market.

Firms make a large number of investments by collaborating, acquiring, and partnering with new emerging startups. The personalized telemedicine app provides a communication platform for remote and real-time monitoring of patients that acts as a bridge between caregiver and patient. This step-change, borne out of necessity, changed the entire look of the remote patient monitoring market post-COVID-19. This change has sped up recovery rates as consumers are more willing to join the app. It has also increased the provider's willingness to use the app, and it offers greater access and reimbursements.

Remote patient monitoring system market size and growth forecast (2023-2033)

The growing collaboration between the healthcare players to advance patient monitoring programs is expected to propel the market growth. For instance, in August 2023, EPIC Health and OMRON Healthcare, Inc. collaborated to address the health inequities in Detroit, U.S. Within the collaboration, OMRON Healthcare will deploy VitalSight, a remote patient monitoring service to diagnose patients suffering from high blood pressure.

AI is revolutionizing remote patient monitoring (RPM) by enabling continuous, real-time analysis of biometric data from connected wearables such as blood pressure cuffs, pulse oximeters, and glucose monitors using advanced algorithms and machine learning. For according to IQVIA, by 2030 over 142 million U.S. patients nearly 40% of the population will be using RPM technologies.

AI enhances RPM by delivering predictive insights and personalized care, helping clinicians detect deterioration early, reducing alert fatigue, and improving clinician workflows. AI-powered RPM systems streamline data processing, triage, and EHR integration, enabling scalable, cost-effective home-based care models. As remote monitoring becomes core to chronic disease management, telehealth, and hospital-at-home programs, AI-enhanced RPM devices are key market drivers for smarter, patient-centric healthcare delivery.

Market Concentration & Characteristics

The degree of innovation in the remote patient monitoring systems market is high, driven by rapid advancements in digital health technologies, growing investments in healthcare IT, and the increasing adoption of AI and machine learning. These innovations enable real-time analytics, predictive insights, and more personalized care delivery. For instance, June 2024, Prevounce Health launched the Pylo GL1‑LTE, a clinically validated, cellular connected blood glucose meter designed for remote patient monitoring programs. It securely transmits real-time glucose readings via multiple cellular networks with laboratory-level accuracy integrating seamlessly with the Prevounce platform and other health systems.

The level of partnerships & collaboration activities by key players in the industry is high, with major players joining forces to enhance technological capabilities, broaden product offerings, and streamline global access to advanced monitoring solutions. For instance, in March 2025, Circadian Health and Tenovi partnered to integrate Tenovi’s RPM platform into Circadian’s chronic disease management programs, using connected devices such as blood pressure monitors and weight scales alongside medication adherence tracking to enhance remote patient support.

Remote Patient Monitoring System Industry Dynamics

The impact of regulations in the remote patient monitoring systems industry is high, as healthcare providers must comply with strict data privacy, security, and interoperability standards. Laws such as HIPAA in the United States, GDPR in Europe, and other regional regulations mandate secure storage, access, and sharing of patient information. In addition, governing bodies promoting electronic health records (EHRs) and value-based care models further intensify the need for regulated, interoperable data infrastructure.

The remote patient monitoring systems industry is experiencing moderate to high regional expansion as healthcare systems worldwide increasingly recognize the importance of centralized, interoperable data platforms. While North America and Europe lead due to advanced healthcare infrastructure and supportive regulatory frameworks, emerging markets in Asia-Pacific, Latin America, and the Middle East are rapidly adopting digital health technologies.

Product Insights

The special monitors segment led the market with a share of 89.95% in 2024 due to its ability to monitor clinically important data pre- and post-surgery, identify symptoms, and prevent complications. Advanced features such as wireless communication and iPad connectivity allow early diagnosis and higher applicability of the products. Vital sign monitors can effectively track a patient's ECG, noninvasive blood pressure, body temperature, respiration rate, and brain activity. Integration of more than one vital sign monitor in a single system is expected to boost the popularity of these products, thereby leading to increased adoption during the forecast period.

Vital sign monitors are commonly used, and the segment is expected to witness the fastest CAGR over the forecast period. Heart rate monitor is identified as the dominating product sub-segment due to the increasing incidence of cardiac conditions globally. The surge in the number of individuals with heart disorders has led to the increased usage of these monitors. In November 2022, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. launched VS9, a vital sign monitoring device. The device can perform multifaceted functions such as non-invasive blood pressure, pulse oximetry, and temperature measurements.

Application Insights

Diabetes emerged as the leading application segment in 2024 and accounted for 13.47% of the market share. Diabetes is one of the leading causes of death, which requires continuous monitoring of blood glucose levels. It is known to affect various body functions including heart activity, vision, liver function, and renal activity. Continuous and routine monitoring is required in diabetes, which can be easily accomplished using remote patient monitoring devices.

The hypertension application segment is also expected to witness significant growth over the forecast period. Hypertension increases the risk of cardiovascular diseases. According to the World Health Organization (WHO), over 1 billion people have hypertension worldwide. Remote patient monitoring can play a key role in controlling hypertension. The cardiovascular disease treatment segment is expected to witness lucrative growth of 20.78% over the forecast period, due to the increasing prevalence of cardiovascular diseases globally.

End Use Insights

The hospital-based patient segment was the leading end use segment in 2024 and accounted for the market share of 61.10%. Hospitals cater to a large number of outpatients as well as inpatients. They offer a large number of diagnostic tests and have a larger technical staff to cater the needs of the patients. The large patient pool and increasing number of tests being performed are the vital drivers for the segment's growth.

Remote Patient Monitoring System Market Share

However, alternate site monitoring, especially home healthcare, is anticipated to exhibit a sturdy CAGR over the forecast period. The cost-efficiency of this alternate site along with the availability of qualified resources is expected to support the growth. Considering the increasing strain on hospital resources and personnel, remote patient monitoring presents market players with huge opportunities in terms of partnering with hospitals & other healthcare settings and launching new products to facilitate affordable care at a patient’s home. Besides this, COVID-19 increased the number of patients interacting with their doctors from home, boosting demand for the remote patient monitoring system.

Regional Insights

North America remote patient monitoring systems market dominated the remote patient monitoring system industry in 2024, accounting for market share of 40.53%. The increase in the incidence of chronic diseases, demand for wireless and portable systems coupled with the presence of sophisticated reimbursement structures aimed at cutting out-of-pocket expenditure are the major factors attributed to the regional growth.

Remote Patient Monitoring System Market Trends, by Region, 2025 - 2033

U.S. Remote Patient Monitoring System Market Trends

The U.S. remote patient monitoring systems market is experiencing strong growth driven by the rising prevalence of chronic diseases such as diabetes, hypertension, and heart failure, along with a rapidly aging population requiring continuous care. Increased adoption of telehealth, supportive reimbursement policies, and the shift towards value-based care models have accelerated RPM integration across hospitals, homecare settings, and outpatient facilities.

Europe Remote Patient Monitoring System Market Trends

Europe, especially the Western European countries, is expected to remain the second most revenue-generating region over the forecast period due to the higher mortality rate and rising demand for low-cost treatment. Rising demand for in-house monitoring, supportive central data management systems, and rising accuracy and efficiency of remote patient monitors are the high-impact rendering drivers for the regional growth. 

UK remote patient monitoring system market is growing focus on reducing hospital pressures and managing long-term conditions is accelerating the adoption of remote patient monitoring (RPM) systems. The National Health Service (NHS) is actively promoting digital care pathways, with RPM playing a central role in supporting patients with conditions such as COPD, heart failure, and diabetes. NHS England’s Virtual Wards initiative has provided a formal structure for remote monitoring, aiming to treat patients safely at home while freeing up hospital beds.

Remote patient monitoring system market in Germany is rising prevalence of chronic conditions and the need for long-term outpatient care are key drivers for remote patient monitoring (RPM) adoption. Healthcare providers are increasingly relying on RPM tools to manage patients with heart failure, diabetes, and COPD outside traditional clinical settings. These systems reduce avoidable hospital admissions and support early intervention through continuous data capture. With a healthcare model that emphasizes preventive care and patient self-management, RPM fits well into existing care pathways.

Asia Pacific Remote Patient Monitoring System Market Trends

Asia Pacific is expected to witness the fastest CAGR over the forecast period owing to the presence of untapped opportunities in the emerging markets of India and China. The expansion of mobile connectivity and smartphone usage has improved the feasibility of deploying RPM systems across diverse populations. In May 2024, BM Birla Heart Hospital in India partnered with Dozee to implement AI-powered connected beds for continuous remote patient monitoring in cardiac wards.

China remote patient monitoring system market is growing due to country’s healthcare system is under pressure from rising chronic disease prevalence and an aging population, prompting interest in remote patient monitoring systems. RPM is being adopted to reduce hospital congestion and extend care to under-resourced rural areas. Government initiatives promoting digital health and telemedicine are encouraging wider deployment. The strong domestic tech ecosystem is enabling rapid development of connected monitoring platforms

Remote patient monitoring system market in India is witnessing the growth due to the Covid-19 pandemic normalized virtual care, creating momentum for wider RPM adoption. RPM is becoming a key element in India’s evolving healthcare delivery models as infrastructure improves. In February 2025, Kauvery Hospital Group’s investment arm, Healthcare Capital, invested an undisclosed amount in Lifesigns. The company develops AI-driven remote patient monitoring solutions that offer predictive alerts and real-time insights. The funding will support the enhancement of its AI algorithms, upcoming product launches, and broader expansion efforts.

Latin America Remote Patient Monitoring System Market Trends

The growing burden of chronic conditions such as diabetes, cardiovascular disease, and respiratory disorders is pushing healthcare systems in Latin America to explore remote patient monitoring systems. RPM offers a scalable solution to extend care access across geographically dispersed and underserved regions. Increasing urban-rural health disparities have made continuous, remote care particularly relevant for improving outcomes.

Middle East & Africa Remote Patient Monitoring System Market Trends

Healthcare systems across the Middle East and Africa are increasingly turning to remote patient monitoring systems to address access gaps and infrastructure challenges. In regions with physician shortages and limited specialist coverage, RPM is emerging as a tool to extend care beyond urban hospitals. Rising incidence of chronic diseases is prompting governments to explore technology-driven care models.

Key Remote Patient Monitoring System Company Insights

The market is highly fragmented, with many small and large players operating in this space. This leads to intense competition between smaller players to sustain their position. Strategies such as new product launches and partnerships are playing a key role in propelling the market growth.

Key Remote Patient Monitoring System Companies:

The following are the leading companies in the remote patient monitoring system market. These companies collectively hold the largest market share and dictate industry trends.

  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • Nihon Kohden Corporation
  • Omron Corporation
  • OSI Systems, Inc.
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd
  • Welch Allyn
  • Smiths Medical
  • Abbott
  • Boston Scientific Corporation
  • Dräger Medical
  • GE Healthcare
  • Honeywell
  • Johnson & Johnson
  • LifeWatch
  • Medtronic
  • Masimo
  • Vitls, Inc
  • CareValidate
  • Biotronik
  • American Telecare

Recent developments

  • In April 2025 Validic partnered with Tenovi to enhance remote patient monitoring through the integration of Tenovi’s cellular-connected medical devices with Validic’s EHR-integrated platform.

Every person deserves access to affordable, quality healthcare enabled by advanced digital health solutions, regardless of their location or economic status. This integration enables health systems to deliver personalized, proactive care more effectively, without adding workflow burden or requiring patients to navigate complex technology”.

-said Drew Schiller, CEO and Co-founder of Validic

  • In Janauary 2025, Smart Meter expanded its RPM footprint by integrating its iBloodPressure Classic, iGlucose cellular meters, and SmartTouch platform into over 350,000 patient setups, supported by a new 25,000 sq. ft. Tampa facility and a growing EHR integration with eClinicalWorks.

“We are grateful to our 900 SmartPartners across the US who entrust us with delivering millions of vital sign readings to their platforms and their providers for better patient care.”

- Casey Pittock, CEO.

  • In September 2024, Veridian acquired Zewa to strengthen its respiratory and RPM device portfolio, gaining products such as nebulizers, oximeters, and connected BP monitors.

“This combination expands Veridian's RPM, consumer medical product portfolio, and telehealth segments positioning the company as a leading supplier in the diagnostic medical and telehealth product categories in North America. Veridian will benefit from Zewa's technology capabilities and diverse product line, providing additional product solutions to its customers."

- John Aldridge, Chief Digital Health Officer of Veridian. 

  • In December 2023, CoachCare acquired Verustat to expand its remote patient monitoring (RPM) footprint, integrating Verustat's primary care and cardiology-focused services.

“We have gotten to know the Verustat team over the past year and their approach to remote care aligns well with CoachCare. We are pleased to welcome their clients and staff to CoachCare and to continue growing our best in class remote care platform.”

-Wes Haydon, President and Co-Founder of CoachCare. “

Remote Patient Monitoring System Market Report Scope

Report Attribute

Details

Market size value in 2025

USD 26.04 billion

Revenue forecast in 2033

USD 110.71 billion

Growth rate

CAGR of 19.8% from 2025 to 2033

Actual data

2021 - 2024

Forecast period

2025 - 2033

Quantitative units

Revenue in USD million/billion and CAGR from 2025 to 2033

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, application, end use, and region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Norway; Denmark; Sweden; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; Saudi Arabia; South Africa; UAE; Kuwait

Key companies profiled

Shenzhen Mindray Bio-Medical Electronics Co., Ltd; Nihon Kohden Corporation; Omron Corporation; OSI Systems, Inc.; Koninklijke Philips N.V.; F. Hoffmann-La Roche Ltd; Welch Allyn; Smiths Medical; Abbott; Boston Scientific Corporation; Dräger Medical; GE Healthcare; Honeywell; Johnson & Johnson; LifeWatch; Medtronic; Masimo; Vitls Inc.; CareValidate; Biotronik; American Telecare.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Remote Patient Monitoring System Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global remote patient monitoring systems market report based on product, application, end use and region.

Global Remote Patient Monitoring System Market Report Segmentation

  • Product Outlook (Revenue, USD Million, 2021 - 2033)

    • Vital Sign Monitors

      • Blood Pressure Monitors

      • Pulse Oximeters

      • Heart Rate Monitor (ECG)

      • Temperature Monitor

      • Respiratory Rate Monitor

      • Brain Monitoring (EEG)

    • Special Monitors

      • Anesthesia Monitors

      • Blood Glucose Monitors

      • Cardiac Rhythm Monitor

      • Respiratory Monitor

      • Fetal Heart Monitors

      • Prothrombin Monitors

      • Multi Parameter Monitors (MPM)

      • Others

  • Application Outlook (Revenue, USD Million, 2021 - 2033)

    • Cancer

    • Cardiovascular Diseases

    • Diabetes

    • Sleep Disorder

    • Weight management and Fitness Monitoring

    • Bronchitis

    • Infections

    • Virus

    • Dehydration

    • Hypertension

  • End Use Outlook (Revenue, USD Million, 2021 - 2033)

    • Hospitals Based Patients

    • Ambulatory Patients

    • Home Healthcare

  • Regional Outlook (Revenue, USD Million, 2021 - 2033)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • China

      • Japan

      • India

      • South Korea

      • Australia

      • Thailand

    • Latin America

      • Brazil

      • Argentina

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Frequently Asked Questions About This Report

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo